Patrick P. Fourteau
Chief Executive Officer at New Haven Pharmaceuticals, Inc.
Patrick P. Fourteau active positions
Companies | Position | Start | End |
---|---|---|---|
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Chief Executive Officer | - | - |
President | - | - |
Career history of Patrick P. Fourteau
Former positions of Patrick P. Fourteau
Companies | Position | Start | End |
---|---|---|---|
REPROS THERAPEUTICS INC | Chairman | 2016-05-11 | 2018-01-30 |
Independent Dir/Board Member | 2016-05-11 | 2018-01-30 | |
INSYS THERAPEUTICS, INC. | Director/Board Member | 2011-05-11 | 2017-10-28 |
Independent Dir/Board Member | 2011-05-11 | 2017-10-28 | |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Director/Board Member | 2011-05-01 | 2011-05-01 |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Director/Board Member | 2003-04-30 | 2010-07-01 |
Chief Executive Officer | 2003-11-17 | 2010-07-01 | |
President | 2003-04-30 | 2010-07-01 | |
Syneos Health Commercial Services LLC
Syneos Health Commercial Services LLC Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., Syneos Health Commercial Services LLC is a private company that provides outsourced product development and commercialization services. The company is based in Somerset, NJ. | President | 2001-12-31 | 2002-12-31 |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Sales & Marketing | 2001-12-31 | 2001-12-31 |
ST JUDE MEDICAL INC | Corporate Officer/Principal | 1999-12-31 | 1999-12-31 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Training of Patrick P. Fourteau
Harvard University | Masters Business Admin |
University of California, Berkeley | Graduate Degree |
Statistics
International
United States | 12 |
Operational
Director/Board Member | 3 |
President | 3 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 8 |
Consumer Services | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Private companies | 8 |
---|---|
St. Jude Medical LLC
St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Repros Therapeutics, Inc.
Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Health Technology |
Syneos Health Commercial Services LLC
Syneos Health Commercial Services LLC Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., Syneos Health Commercial Services LLC is a private company that provides outsourced product development and commercialization services. The company is based in Somerset, NJ. | Commercial Services |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
INSYS Therapeutics, Inc.
INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
- Stock Market
- Insiders
- Patrick P. Fourteau
- Experience